Impact of tumour size measurement inter‑operator variability on model‑based drug effect evaluation

Autor: Hitesh Mistry, Ivelina Gueoguieva, Aurélie Lombard, Leon Aarons, Kayode Ogungbenro, Sonya C. Chapman

Publikováno v: Lombard, A, Mistry, H, Chapman, S C, Gueoguieva, I, Aarons, L & Ogungbenro, K 2020, ' Impact of tumour size measurement inter‑operator variability on model‑based drug effect evaluation ', Cancer Chemotherapy and Pharmacology . https://doi.org/10.1007/s00280-020-04049-5
Cancer Chemotherapy and Pharmacology

Purpose During oncology clinical trials, tumour size (TS) measurements are commonly used to monitor disease progression and to assess drug efficacy. We explored inter-operator variability within a subset of a phase III clinical trial conducted from A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5007ce3deedc67b82b74ac4bf50391f4
https://www.research.manchester.ac.uk/portal/en/publications/impact-of-tumour-size-measurement-interoperator-variability-on-modelbased-drug-effect-evaluation(406eb34a-d1bd-49a4-8c60-af91d7659402).html